ZA897150B - Crf analogs - Google Patents

Crf analogs

Info

Publication number
ZA897150B
ZA897150B ZA897150A ZA897150A ZA897150B ZA 897150 B ZA897150 B ZA 897150B ZA 897150 A ZA897150 A ZA 897150A ZA 897150 A ZA897150 A ZA 897150A ZA 897150 B ZA897150 B ZA 897150B
Authority
ZA
South Africa
Prior art keywords
crf analogs
crf
analogs
Prior art date
Application number
ZA897150A
Other languages
English (en)
Inventor
Jean Edouard Frederic Rivier
Edouard Frederic Rivier Jean
Wylie Walker Vale Jr
Walker Vale Wylie Jr
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of ZA897150B publication Critical patent/ZA897150B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57509Corticotropin releasing factor [CRF] (Urotensin)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
ZA897150A 1988-09-30 1989-09-19 Crf analogs ZA897150B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25167488A 1988-09-30 1988-09-30

Publications (1)

Publication Number Publication Date
ZA897150B true ZA897150B (en) 1990-06-27

Family

ID=22952939

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA897150A ZA897150B (en) 1988-09-30 1989-09-19 Crf analogs

Country Status (10)

Country Link
EP (1) EP0361954A3 (de)
JP (1) JPH03501858A (de)
KR (1) KR0148264B1 (de)
AU (1) AU615805B2 (de)
CA (1) CA1340964C (de)
DK (1) DK130890A (de)
IL (1) IL91663A0 (de)
NZ (1) NZ230731A (de)
WO (1) WO1990003393A1 (de)
ZA (1) ZA897150B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5235036A (en) * 1991-05-31 1993-08-10 The Salk Institute For Biological Studies Crf analogs
JP3243250B2 (ja) * 1990-03-23 2002-01-07 ザ・ソーク・インスティチュート・フォー・バイオロジカル・スタディーズ Crf同族体
AU704838B2 (en) * 1994-09-12 1999-05-06 Trustees Of The University Of Pennsylvania, The Corticotropin release inhibiting factor and methods of using same
US6039956A (en) * 1994-09-12 2000-03-21 Pennsylvania, Trustees Of The University Of, The Corticotropin release inhibiting factor and methods of using same for treating behavioral symptoms in an anxiety disorder
US5824771A (en) * 1994-12-12 1998-10-20 The Salk Institute For Biological Studies Cyclic CRF agonists
US6670140B2 (en) * 2001-03-06 2003-12-30 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792033A (en) * 1969-05-06 1974-02-12 Ciba Geigy Corp Acth-type hormones whose first aminoacid is of d-configuration
BR6915265D0 (pt) * 1969-06-10 1973-04-19 Ciba Geigy Processo para a preparacao de novos peptidios com atividade-acth
US4415558A (en) * 1981-06-08 1983-11-15 The Salk Institute For Biological Studies CRF And analogs
US4489163A (en) * 1983-04-14 1984-12-18 The Salk Institute For Biological Studies rCRF and analogs
DE3587276T2 (de) * 1984-02-23 1993-07-29 Salk Inst For Biological Studi Crf-analoga.

Also Published As

Publication number Publication date
JPH03501858A (ja) 1991-04-25
IL91663A0 (en) 1990-04-29
KR0148264B1 (ko) 1998-10-15
KR900701835A (ko) 1990-12-04
EP0361954A2 (de) 1990-04-04
NZ230731A (en) 1991-12-23
DK130890D0 (da) 1990-05-28
EP0361954A3 (de) 1991-12-04
CA1340964C (en) 2000-04-18
WO1990003393A1 (en) 1990-04-05
DK130890A (da) 1990-05-28
AU4339889A (en) 1990-04-18
AU615805B2 (en) 1991-10-10

Similar Documents

Publication Publication Date Title
GB8909571D0 (en) Novel cyclopentano-vitamin d analogs
ZA851129B (en) Crf analogs
GB8806990D0 (en) Novel compounds
EP0516450A3 (en) Crf analogs
GB8829571D0 (en) Antiviral compounds
ZA897150B (en) Crf analogs
GB8808926D0 (en) Novel compounds
GB8809534D0 (en) Novel compounds
IE893131L (en) Crf analogs
ZA892971B (en) Tyr-peptide analogs
GB8813680D0 (en) Antiviral compounds
GB8813679D0 (en) Antiviral compounds
GB8810319D0 (en) Antiviral compounds
GB8803920D0 (en) Novel compounds
GB8801406D0 (en) Novel compounds
GB8801492D0 (en) Novel compounds
GB8801493D0 (en) Novel compounds
GB8801494D0 (en) Novel compounds
GB8801495D0 (en) Novel compounds
GB8801496D0 (en) Novel compounds
GB8803514D0 (en) Novel compounds
GB8803919D0 (en) Novel compounds
GB8801487D0 (en) Novel compounds
GB8804224D0 (en) Novel compounds
GB8804421D0 (en) Novel compounds